“…This sex difference is established in utero, probably at the end of the first trimester (Galis, Ten Broek, Van Dongen, & Wijnaendts, 2010;Malas, Dogan, Evcil, & Desdicioglu, 2006), but the sex difference appears largely unaffected by puberty (Králík, Ingrová, Kozieł, Hupková, & Klíma, 2017;McIntyre, Ellison, Lieberman, Demerath, & Towne, 2005;Trivers, Manning, & Jacobson, 2006). 2D:4D shows longitudinal stability (Králík et al, 2017;McIntyre, Cohn, & Ellison, 2006;McIntyre, Ellison, Lieberman, Demerath, & Towne, 2005;Wong & Hines, 2016), but see Knickmeyer, Woolson, Hamer, Konneker, and Gilmore (2011) for an exception. Probably the best evidence that 2D:4D reflects prenatal T effects stems from individuals who were exposed to atypical T effects during early development: Females with high prenatal T levels due to CAH have strongly masculinized 2D:4D (Brown, Hines, Fane, & Breedlove, 2002;Hönekopp & Watson, 2010;Kocaman et al, 2017;Rivas et al, 2014); similarly, men affected by Klinefelter's syndrome, which causes low T levels throughout development, show strongly feminized 2D:4D (Manning, Kilduff, & Trivers, 2013); finally, genetic males affected by CAIS show moderately feminized 2D:4D (Berenbaum, Bryk, Nowak, Quigley, & Moffat, 2009;van Hemmen, Cohen-Kettenis, Steensma, Veltman, & Bakker, 2017).…”